A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis
Open Access
- 22 May 2006
- journal article
- research article
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 64 (3) , 351-357
- https://doi.org/10.1016/j.gie.2005.11.060
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trialGut, 2003
- Bedside Scoring System to Predict the Risk of Developing Pancreatitis Following ERCPEndoscopy, 2002
- Post-ERCP Pancreatitis and Hyperamylasemia: Patient-Related and Operative Risk FactorsEndoscopy, 2002
- Risk factors for post-ERCP pancreatitis: A prospective, multicenter studyGastrointestinal Endoscopy, 2001
- Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatographyGastroenterology, 2001
- Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysisGastrointestinal Endoscopy, 2000
- Gabexate for the Prevention of Pancreatic Damage Related to Endoscopic Retrograde CholangiopancreatographyNew England Journal of Medicine, 1996
- Complications of Endoscopic Biliary SphincterotomyNew England Journal of Medicine, 1996
- Endoscopic Papillotomy for Common Bile Duct Stones: Factors Influencing the Complication RateEndoscopy, 1994
- Complications of endoscopic sphincterotomyGastroenterology, 1991